Results for tag: "Busulfan"

Busulfan is an alkylating agent used in the treatment of certain types of cancer, such as chronic myelogenous leukemia (CML). It is a chemotherapy drug that works by interfering with the growth of cancer cells. The busulfan market is a segment of the oncology drugs market, which is estimated to be worth billions of dollars. Busulfan is used in combination with other drugs to treat CML, and is also used as a conditioning agent prior to bone marrow transplantation. The busulfan market is highly competitive, with several major players offering their own branded versions of the drug. Some of the key players in the market include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Other companies such as Cipla, Dr. Reddy's Laboratories, and Lupin also offer generic versions of the drug. Show Less Read more